Class:

BCR-ABL inhibitors

Adapted from Lee N. et al. Oral chemotherapeutic agents in current use. J Korean Med Assoc. 2011 Nov; 54(11): 1191-1198. doi: 10.5124/jkma.2011.54.11.1191.  

All content on this site is intended for healthcare professionals only. If you are a patient or carer, please visit the Lymphoma Coalition.